Determining Whether YAP1 and POU2F3 Are Antineuroendocrine Factors

Affiliations

¹ Department of Pathology, Tsukuba University Hospital, Ibaraki, Japan; Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
² Division of Molecular Pathology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
³ Department of Pathology, Tsukuba University Hospital, Ibaraki, Japan; Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan; Division of Molecular Pathology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. Electronic address: VZV07574@nifty.com.

Free article

Editorial

Ryota Matsuoka et al. J Thorac Oncol. 2022 Sep.

Free article

. 2022 Sep;17(9):1070-1073.

doi: 10.1016/j.jtho.2022.07.001.

¹ Department of Pathology, Tsukuba University Hospital, Ibaraki, Japan; Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
² Division of Molecular Pathology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
³ Department of Pathology, Tsukuba University Hospital, Ibaraki, Japan; Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan; Division of Molecular Pathology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. Electronic address: VZV07574@nifty.com.

No abstract available

Comment on

POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.
Baine MK, Febres-Aldana CA, Chang JC, Jungbluth AA, Sethi S, Antonescu CR, Travis WD, Hsieh MS, Roh MS, Homer RJ, Ladanyi M, Egger JV, Lai WV, Rudin CM, Rekhtman N. Baine MK, et al. J Thorac Oncol. 2022 Sep;17(9):1109-1121. doi: 10.1016/j.jtho.2022.06.004. Epub 2022 Jun 24. J Thorac Oncol. 2022. PMID: 35760287 Free PMC article.